Novel H1N1 Flu Situation Update
July 17, 2009, 11:00 AM ET

Map: Weekly Influenza Activity Estimates Reported by State and Territorial Epidemiologists
(Activity levels indicate geographic spread of both seasonal and novel influenza A [H1N1] viruses)
(Posted July 17, 2009, 3:00 PM ET, for Week Ending July 11, 2009)

For more details about the data in the map above, see the FluView Surveillance Report for the week ending July 11, 2009. For information about how this map is updated, see Questions & Answers About CDC's Online Reporting.

Table. U.S. Human Cases of H1N1 Flu Infection
Web page updated July 17, 2009,
11:00 AM ET
Data reported to CDC by July 17, 2009, 11:00 AM ET.

States and Territories*	Confirmed and Probable Cases	Deaths
States
Alabama	477 cases	0 deaths
Alaska	218 cases	0 deaths
Arizona	762 cases	11 deaths
Arkansas	47 cases	0 deaths
California	3161 cases	52 deaths
Colorado	155 cases	0 deaths
Connecticut	1581 cases	7 deaths
Delaware	364 cases	0 deaths
Florida	2188 cases	12 deaths
Georgia	174 cases	1 death
Hawaii	722 cases	1 death
Idaho	143 cases	0 deaths
Illinois	3357 cases	15 deaths
Indiana	282 cases	1 death
Iowa	165 cases	0 deaths
Kansas	186 cases	0 deaths
Kentucky	143 cases	0 deaths
Louisiana	232 cases	0 deaths
Maine	133 cases	0 deaths
Maryland	732 cases	3 deaths
Massachusetts	1343 cases	5 deaths
Michigan	515 cases	8 deaths
Minnesota	660 cases	3 deaths
Mississippi	219 cases	0 deaths
Missouri	70 cases	1 death
Montana	94 cases	0 deaths
Nebraska	264 cases	1 death
Nevada	406 cases	0 deaths
New Hampshire	247 cases	0 deaths
New Jersey	1350 cases	14 deaths
New Mexico	232 cases	0 deaths
New York	2670 cases	57 deaths
North Carolina	395 cases	4 deaths
North Dakota	61 cases	0 deaths
Ohio	161 cases	1 death
Oklahoma	176 cases	1 death
Oregon	465 cases	5 deaths
Pennsylvania	1914 cases	8 deaths
Rhode Island	188 cases	2 deaths
South Carolina	244 cases	0 deaths
South Dakota	39 cases	0 deaths
Tennessee	247 cases	1 death
Texas	4975 cases	24 deaths
Utah	966 cases	14 deaths
Vermont	59 cases	0 deaths
Virginia	319 cases	2 deaths
Washington	636 cases	4 deaths
Washington, D.C.	45 cases	0 deaths
West Virginia	227 cases	0 deaths
Wisconsin	6031 cases	5 deaths
Wyoming	106 cases	0 deaths
Territories
American Samoa	8 cases	0 deaths
Guam	1 case	0 deaths
Puerto Rico	18 cases	0 deaths
Virgin Islands	44 cases	0 deaths
TOTAL (55)*	40,617 cases	263 deaths
*Includes the District of Columbia, American Samoa, Guam, Puerto Rico and the U.S. Virgin Islands. This table will be updated each Friday at 11 AM ET. International Human Cases of H1N1 Flu Infection See: World Health Organization. NOTE: Because of daily reporting deadlines, the state totals reported by CDC may not always be consistent with those reported by state health departments. If there is a discrepancy between these two counts, data from the state health departments should be used as the most accurate number. For more information about how these case counts are updated, see Questions & Answers About CDC's Online Reporting.

Summary of Situation

Updated July 10, 2009, 11:00 AM ET

A Pandemic Is Declared

On June 11, 2009, the World Health Organization (WHO) signaled that a global pandemic of novel influenza A (H1N1) was underway by raising the worldwide pandemic alert level to Phase 6. This action was a reflection of the spread of the new H1N1 virus, not the severity of illness caused by the virus. At the time, more than 70 countries had reported cases of novel influenza A (H1N1) infection and there were ongoing community level outbreaks of novel H1N1 in multiple parts of the world.

Since the WHO declaration of a pandemic, the new H1N1 virus has continued to spread, with the number of countries reporting cases of novel H1N1 nearly doubling. The Southern Hemisphere’s regular influenza season has begun and countries there are reporting that the new H1N1 virus is spreading and causing illness along with regular seasonal influenza viruses. In the United States, significant novel H1N1 illness has continued into the summer, with localized and in some cases intense outbreaks occurring. The United States continues to report the largest number of novel H1N1 cases of any country worldwide, however, most people who have become ill have recovered without requiring medical treatment.

Given ongoing novel H1N1 activity to date, CDC anticipates that there will be more cases, more hospitalizations and more deaths associated with this pandemic in the United States over the summer and into the fall and winter. The novel H1N1 virus, in conjunction with regular seasonal influenza viruses, poses the potential to cause significant illness with associated hospitalizations and deaths during the U.S. influenza season.

Background

Novel influenza A (H1N1) is a new flu virus of swine origin that first caused illness in Mexico and the United States in March and April, 2009. It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread, mainly through the coughs and sneezes of people who are sick with the virus, but it may also be spread by touching infected objects and then touching your nose or mouth. Novel H1N1 infection has been reported to cause a wide range of flu-like symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, many people also have reported nausea, vomiting and/or diarrhea.

The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency and has been actively and aggressively implementing the nation’s pandemic response plan

By June 19, 2009, all 50 states in the United States, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands have reported novel H1N1 infection. While nationwide U.S. influenza surveillance systems indicate that overall influenza activity is decreasing in the country at this time, novel H1N1 outbreaks are ongoing in parts of the U.S., in some cases with intense activity.

CDC is continuing to watch the situation carefully, to support the public health response and to gather information about this virus and its characteristics. The Southern Hemisphere is just beginning its influenza season and the experience there may provide valuable clues about what may occur in the Northern Hemisphere this fall and winter.

CDC Response

CDC continues to take aggressive action to respond to the outbreak. CDC’s response goals are to reduce the spread and severity of illness, and to provide information to help health care providers, public health officials and the public address the challenges posed by this new public health threat.

CDC is issuing updated interim guidance in response to the rapidly evolving situation.

Clinician Guidance

CDC has issued interim guidance for clinicians on identifying and caring for patientswith novel H1N1, in addition to providing interim guidance on the use of antiviral drugs. Influenza antiviral drugs are prescription medicines (pills, liquid or an inhaled powder) with activity against influenza viruses, including novel influenza H1N1 viruses. The priority use for influenza antiviral drugs during this outbreak is to treat people hospitalized with influenza illness, and to treat people at increased risk of severe illness, including pregnant women, young children, and people with chronic health conditions like asthma, diabetes and other metabolic diseases, heart or lung disease, kidney disease, weakened immune systems, and persons with neurologic or neuromuscular disease.

Public Guidance

CDC has provided guidance for the public on what to do if they become sick with flu-like symptoms, including infection with novel H1N1. CDC also has issued instructions on taking care of a sick person at home and the use of facemasks and respirators to reduce novel influenza A (H1n1) transmission. Everyone should take everyday preventive actions to stop the spread of germs, including frequent hand washing and people who are sick should stay home and avoid contact with others in order to limit further spread of the disease.

Testing

CDC has developed a PCR diagnostic test kit to detect this novel H1N1 virus and has now distributed test kits to all states in the U.S. and the District of Columbia and Puerto Rico. The test kits are being shipped internationally as well. This will allow states and other countries to test for this new virus.

Vaccine

Vaccines are a very important part of a response to novel H1N1 influenza and the U.S. Government is aggressively taking early steps in the process to manufacture a novel H1N1 vaccine, working closely with manufacturers. CDC isolated the new H1N1 virus, made a candidate vaccine virus strain that can be used to create vaccine, and is working with other agencies and industry to begin scaling up for testing and production of a vaccine. Making vaccine is a long multi-step process requiring several months to complete. CDC has developed guidance for state and local public health departments to assist them in planning for a novel H1N1 influenza vaccination campaign. Additional guidance is forthcoming.

Stockpile Deployment

CDC has deployed 25 percent of the supplies in the Strategic National Stockpile (SNS) to all states in the continental United States and U.S. territories. This included antiviral drugs, personal protective equipment, and respiratory protection devices. These supplies and medicines will help states and U.S. territories respond to novel H1N1 virus.

Surveillance

Novel influenza A (H1N1) activity is being detected through CDC’s routine influenza surveillance systems and reported weekly in FluView. CDC tracks U.S. influenza activity through multiple systems. While our influenza surveillance systems indicate that overall influenza activity is decreasing in the United States, novel H1N1 outbreaks are ongoing in different parts of the U.S., in some cases with intense influenza-like activity. Nearly 100 percent of the influenza viruses being detected now are novel H1N1 viruses.

Shared Responsibility

Individuals have an important role in protecting themselves and their families.

• Stay informed. Health officials will provide additional information as it becomes available
• Everyone should take these everyday steps to protect your health and lessen the spread of this new virus:
  • Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it.
  • Wash your hands often with soap and water, especially after you cough or sneeze. Alcohol-based hand cleaners are also effective.
  • Avoid touching your eyes, nose or mouth. Germs spread this way.
  • Try to avoid close contact with sick people.
  • If you are sick with a flu-like illness, stay home for 7 days after your symptoms begin or until you have been symptom-free for 24 hours, whichever is longer. This is to keep from infecting others and spreading the virus further.
  • Follow public health advice regarding school closures, avoiding crowds and other social distancing measures.

More on the WHO Pandemic Declaration

• Statement from HHS Secretary Sebelius & DHS Secretary Napolitano
• Webcast: U.S. Response to Pandemic Declaration
• CDC Press Conference Transcript
• WHO Press Conference

More on the Situation

• Guidance
• Reports & Publications
• Press Briefing
• Past Updates on the Situation
• Questions & Answers About CDC's Online Reporting